Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge

DeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, Mallory Shriver, Catherine Cox, Jessica Butts, Jordan S Lundeen, Kathleen A Strauss, Sudhaunshu Joshi, Biraj Shrestha, Annie X Mo, Effie Y H Nomicos, Gregory A Deye, Jason A Regules, Elke S Bergmann-Leitner, Marcela F Pasetti, Matthew B Laurens

Open source

DOI: 10.1093/infdis/jiae062
Published: 2024-02-08
Container: The Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiae062,
  title = {Recombinant Full-length <i>Plasmodium falciparum</i> Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome <i>Quillaja saponaria</i> 21: Results of Phase 1 Testing With Malaria Challenge},
  author = {DeAnna J Friedman-Klabanoff and Andrea A Berry and Mark A Travassos and Mallory Shriver and Catherine Cox and Jessica Butts and Jordan S Lundeen and Kathleen A Strauss and Sudhaunshu Joshi and Biraj Shrestha and Annie X Mo and Effie Y H Nomicos and Gregory A Deye and Jason A Regules and Elke S Bergmann-Leitner and Marcela F Pasetti and Matthew B Laurens},
  year = {2024},
  journal = {The Journal of Infectious Diseases},
  doi = {10.1093/infdis/jiae062},
  url = {https://doi.org/10.1093/infdis/jiae062}
}

RIS

TY  - JOUR
TI  - Recombinant Full-length <i>Plasmodium falciparum</i> Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome <i>Quillaja saponaria</i> 21: Results of Phase 1 Testing With Malaria Challenge
AU  - DeAnna J Friedman-Klabanoff
AU  - Andrea A Berry
AU  - Mark A Travassos
AU  - Mallory Shriver
AU  - Catherine Cox
AU  - Jessica Butts
AU  - Jordan S Lundeen
AU  - Kathleen A Strauss
AU  - Sudhaunshu Joshi
AU  - Biraj Shrestha
AU  - Annie X Mo
AU  - Effie Y H Nomicos
AU  - Gregory A Deye
AU  - Jason A Regules
AU  - Elke S Bergmann-Leitner
AU  - Marcela F Pasetti
AU  - Matthew B Laurens
PY  - 2024
JO  - The Journal of Infectious Diseases
DO  - 10.1093/infdis/jiae062
UR  - https://doi.org/10.1093/infdis/jiae062
ER  -

APA

Friedman-Klabanoff, D. J., Berry, A. A., Travassos, M. A., Shriver, M., Cox, C., Butts, J., Lundeen, J. S., Strauss, K. A., Joshi, S., Shrestha, B., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Regules, J. A., Bergmann-Leitner, E. S., Pasetti, M. F., & Laurens, M. B. (2024). Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae062

Source records

crossref · retrieved 2026-09-25T01:47:22.427Z